PAB should be $100m market cap at time of clinical trials. yearly highs to be broken.
https://www.patrys.com/site/in-the-news/Bioshares_PAB_28Sept2020.pdf
"Patrys expects its lead compound to enter clinical studies towards the end of next year. A transaction for its lead program may occur before then."
- Forums
- ASX - By Stock
- PAB
- Ann: PAB Business Review - 30 June 2020
Ann: PAB Business Review - 30 June 2020, page-60
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $6.609K | 944.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 7332773 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 3366521 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 7332773 | 0.007 |
12 | 3480180 | 0.006 |
10 | 3819992 | 0.005 |
8 | 6299000 | 0.004 |
2 | 1829016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 3366521 | 8 |
0.009 | 1929459 | 4 |
0.010 | 251500 | 2 |
0.011 | 1360000 | 4 |
0.012 | 372407 | 3 |
Last trade - 10.06am 21/05/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |